publication date: Mar. 23, 2018

Congressional omnibus gives NIH a surprisingly hefty $3 billion raise

By Paul Goldberg

Congress March 22 passed a budget that gives a stunning $3 billion increase to NIH and a $275 million boost to NCI.

Legislators prepared the nearly 2,300-page omnibus bill to reach President Trump’s desk before the government runs out of money—and before Trump’s scheduled departure for Florida—on March 23.

After balking at signing the bill earlier on March 23, Trump ultimately signed it.

Overall, the bill provides $37 billion for NIH and $5.7 billion for NCI. This raise for NIH is a full $1 billion above the previously expected best-case scenario. Congress doled out these funds in a last-minute maneuver after raising the budgetary spending caps.

“The AACR is extremely appreciative that lawmakers were able to work in a bipartisan fashion to ensure that our nation’s priorities, including NIH and FDA, are receiving momentous funding increases in FY 2018. In fact, the $3 billion funding increase that Congress is providing to the NIH in FY 2018 represents the single largest annual appropriations funding increase since Congress embarked on its five-year plan to double the agency’s budget between 1998 and 2003,” said Jon Retzlaff, vice president, science policy and government affairs at the American Association for Cancer Research, said to The Cancer Letter. “It’s really an incredible result, where Congress is providing even far more funding to the NIH than either the House or Senate initially proposed in their respective subcommittee bills. Additionally, the $15 million in funding that was provided for the FDA’s Oncology Center of Excellence is an extremely important step forward for cancer patients and their loved ones, as the relatively recently established … Continue reading Congressional omnibus gives NIH a surprisingly hefty $3 billion raise

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.